Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme.

Fish, Rebecca; Renehan, Andrew G; Punnett, Grant; Aziz, Omer; Fulford, Paul E; Selvasekar, Chelliah; Wilson, Malcolm S; Halstead, Rebecca; O'Dwyer, Sarah T

dc.contributor.author	Fish, Rebecca
dc.contributor.author	Renehan, Andrew G
dc.contributor.author	Punnett, Grant
dc.contributor.author	Aziz, Omer
dc.contributor.author	Fulford, Paul E
dc.contributor.author	Selvasekar, Chelliah
dc.contributor.author	Wilson, Malcolm S
dc.contributor.author	Halstead, Rebecca
dc.contributor.author	O'Dwyer, Sarah T
dc.date.accessioned	2018-07-21T09:19:52Z
dc.date.available	2018-07-21T09:19:52Z
dc.date.issued	2018-06-19
dc.identifier.citation	Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme. 2018, Colorectal Dis	en
dc.identifier.issn	1463-1318
dc.identifier.pmid	29920919
dc.identifier.doi	10.1111/codi.14310
dc.identifier.uri	http://hdl.handle.net/10541/621144
dc.description.abstract	Pseudomyxoma peritonei (PMP) is a rare neoplasm of the appendix, which if untreated disseminates throughout the abdominal cavity and generates considerable morbidity. Since 2002 in the UK, patients with PMP have been managed via two nationally commissioned centres. We evaluated referrals and treatment pathways over time at the Manchester centre.
dc.language.iso	en	en
dc.rights	Archived with thanks to Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland	en
dc.title	Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme.	en
dc.type	Article	en
dc.contributor.department	Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, United Kingdom	en
dc.identifier.journal	Colorectal Disease	en
refterms.dateFOA	2020-04-27T11:18:07Z
html.description.abstract	Pseudomyxoma peritonei (PMP) is a rare neoplasm of the appendix, which if untreated disseminates throughout the abdominal cavity and generates considerable morbidity. Since 2002 in the UK, patients with PMP have been managed via two nationally commissioned centres. We evaluated referrals and treatment pathways over time at the Manchester centre.